AstraZeneca, meanwhile, has said Britain’s health regulator has started an ‘accelerated’ review. Its vaccine candidate is called ‘AZD1222’ and is being developed in partnership with the University of Oxford.
from Hindustan Times - world https://ift.tt/35XKsF5
No comments:
Post a Comment